KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Active as of 2022-07-13 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="TreatmentRegimen"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet TreatmentRegimen</b></p><a name="TreatmentRegimen"> </a><a name="hcTreatmentRegimen"> </a><ul><li>Include these codes as defined in <a href="CodeSystem-TreatmentRegimen.html"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hydrea">hydrea</a></td><td>Hydrea</td><td>Hydrea</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hdara_c">hdara_c</a></td><td>HdAraC</td><td>Hd-Ara-c +- supplement</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087">da31087</a></td><td>DA inkl. 3+10, 3+8, 3+7</td><td>DA inkl. 3+10, 3+8, 3+7</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087my">da31087my</a></td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-da31087mi">da31087mi</a></td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmito">flagmito</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-flagmitovene">flagmitovene</a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-idarac">idarac</a></td><td>IdAraC</td><td>IdAraC</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-apl_mt">apl_mt</a></td><td>APL vedligehold</td><td>APL-vedligeholdsbehandling</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinmono">azacitidinmono</a></td><td>Azacitidin monoterapi</td><td>Azacitidin monoterapi</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-blinatumomab">blinatumomab</a></td><td>Blinatumunab</td><td>Blinatumomab</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-vyxeos">vyxeos</a></td><td>Vyxeos</td><td>Vyxeos +- supplement</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-nopho_2008">nopho_2008</a></td><td>NOPHO 2008</td><td>NOPHO-2008</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-atoatra">atoatra</a></td><td>ATO+ATRA</td><td>ATO+ATRA</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-aida">aida</a></td><td>AIDA</td><td>AIDA</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-azacitidinvene">azacitidinvene</a></td><td>Azacitidin-venetoclax</td><td>Azacitidin-venetoclax</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-toplusfem">toplusfem</a></td><td>2+5 eller lign, eks. CT</td><td>2+5 eller lign, eks. CT</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-gilteritinib">gilteritinib</a></td><td>Gilteritinib</td><td>Gilteritinib</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-midostaurin_ved">midostaurin_ved</a></td><td>Midostaurin vedligehold</td><td>Midostaurin vedligehold</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-inotuzumab">inotuzumab</a></td><td>Inotuzumab ozogamicin</td><td>Inotuzumab ozogamicin</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-all_ved">all_ved</a></td><td>ALL vedligehold</td><td>ALL vedligehold</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-hyper_cvad">hyper_cvad</a></td><td>Hyper-CVAD</td><td>Hyper-CVAD</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-alltogether_mt">alltogether_mt</a></td><td>ALLtogether</td><td>ALLtogether</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_ikke">other_ikke</a></td><td>Anden ikke-intensiv</td><td>Anden ikke-intensiv</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_eks">other_eks</a></td><td>Anden eksperimentel</td><td>Anden eksperimentel</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_semi">other_semi</a></td><td>Anden semiintensiv (f.eks. Plan B)</td><td>Anden semiintensiv (f.eks. Plan B)</td></tr><tr><td><a href="CodeSystem-TreatmentRegimen.html#TreatmentRegimen-other_int">other_int</a></td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td></tr></table></li></ul></div>
</text>
<url value="https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen"/>
<version value="2.12.0"/>
<name value="TreatmentRegimen"/>
<title value="Behandlingsplan"/>
<status value="active"/>
<experimental value="true"/>
<date value="2022-07-13T00:00:00+02:00"/>
<publisher
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<contact>
<name
value="Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"/>
<telecom>
<system value="url"/>
<value value="https://trifork.com"/>
</telecom>
<telecom>
<system value="email"/>
<value value="rbk@trifork.com"/>
</telecom>
</contact>
<description
value="Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling"/>
<compose>
<include>
<system value="https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen"/>
<concept>
<code value="hydrea"/>
<display value="Hydrea"/>
</concept>
<concept>
<code value="hdara_c"/>
<display value="HdAraC"/>
</concept>
<concept>
<code value="da31087"/>
<display value="DA inkl. 3+10, 3+8, 3+7"/>
</concept>
<concept>
<code value="da31087my"/>
<display value="DA inkl. 3+10, 3+8, 3+7 + mylotarg"/>
</concept>
<concept>
<code value="da31087mi"/>
<display value="DA inkl. 3+10, 3+8, 3+7 + midostaurin"/>
</concept>
<concept>
<code value="flagmito"/>
<display value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG"/>
</concept>
<concept>
<code value="flagmitovene"/>
<display
value="FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"/>
</concept>
<concept>
<code value="idarac"/>
<display value="IdAraC"/>
</concept>
<concept>
<code value="apl_mt"/>
<display value="APL vedligehold"/>
</concept>
<concept>
<code value="azacitidinmono"/>
<display value="Azacitidin monoterapi"/>
</concept>
<concept>
<code value="blinatumomab"/>
<display value="Blinatumunab"/>
</concept>
<concept>
<code value="vyxeos"/>
<display value="Vyxeos"/>
</concept>
<concept>
<code value="nopho_2008"/>
<display value="NOPHO 2008"/>
</concept>
<concept>
<code value="atoatra"/>
<display value="ATO+ATRA"/>
</concept>
<concept>
<code value="aida"/>
<display value="AIDA"/>
</concept>
<concept>
<code value="azacitidinvene"/>
<display value="Azacitidin-venetoclax"/>
</concept>
<concept>
<code value="toplusfem"/>
<display value="2+5 eller lign, eks. CT"/>
</concept>
<concept>
<code value="gilteritinib"/>
<display value="Gilteritinib"/>
</concept>
<concept>
<code value="midostaurin_ved"/>
<display value="Midostaurin vedligehold"/>
</concept>
<concept>
<code value="inotuzumab"/>
<display value="Inotuzumab ozogamicin"/>
</concept>
<concept>
<code value="all_ved"/>
<display value="ALL vedligehold"/>
</concept>
<concept>
<code value="hyper_cvad"/>
<display value="Hyper-CVAD"/>
</concept>
<concept>
<code value="alltogether_mt"/>
<display value="ALLtogether"/>
</concept>
<concept>
<code value="other_ikke"/>
<display value="Anden ikke-intensiv"/>
</concept>
<concept>
<code value="other_eks"/>
<display value="Anden eksperimentel"/>
</concept>
<concept>
<code value="other_semi"/>
<display value="Anden semiintensiv (f.eks. Plan B)"/>
</concept>
<concept>
<code value="other_int"/>
<display value="Anden intensiv (f.eks. BISHOP, Plan A)"/>
</concept>
</include>
</compose>
</ValueSet>